IL DONG PHARMACEUTICAL CO., LTD.
Develops & manufactures pharmaceuticals, APIs, and offers CMO services for various diseases.
249420 | KO
Overview
Corporate Details
- ISIN(s):
- KR7249420001
- LEI:
- Country:
- South Korea
- Address:
- 서울특별시 서초구 바우뫼로27길 2, 서초구
- Sector:
- Manufacturing
- Industry:
- Manufacture of pharmaceuticals, medicinal chemical and botanical products
Description
IL DONG PHARMACEUTICAL CO., LTD. is a healthcare company specializing in the research, development, manufacturing, and commercialization of pharmaceutical products. The company's business spans finished drugs, active pharmaceutical ingredients (APIs), and contract manufacturing (CMO) services, utilizing its GMP-certified facilities. Its therapeutic focus includes metabolic disorders, respiratory diseases, oncology, cardiovascular conditions, and gastrointestinal diseases. Ildong Pharmaceutical is committed to innovation, advancing a robust pipeline of novel drug candidates such as oral GLP-1 agonists for diabetes/obesity and first-in-class treatments for fibrotic diseases, partly through its spin-off iLeadBMS. The company is actively expanding its global market presence through strategic partnerships, licensing, and exports.
Unlock This Filing & Millions More
You're one step away from the data you need. Create a free account to instantly view this filing and get access to powerful research tools.
Filings
| Date | Filing | Language | Size | Actions | |
|---|---|---|---|---|---|
| 2025-09-11 00:00 |
Major Shareholding Notification
주식등의대량보유상황보고서(일반)
|
Korean | 129.5 KB | ||
| 2025-09-11 00:00 |
Major Shareholding Notification
최대주주등소유주식변동신고서
|
Korean | 42.4 KB | ||
| 2025-09-09 00:00 |
Report Publication Announcement
기업설명회(IR)개최(안내공시)
|
Korean | 6.4 KB | ||
| 2025-08-14 00:00 |
Interim Report
반기보고서 (2025.06)
|
Korean | 3.5 MB | ||
| 2025-07-30 00:00 |
Governance Information
공정거래자율준수프로그램운영현황(안내공시)
|
Korean | 16.9 KB | ||
| 2025-07-30 00:00 |
Earnings Release
영업(잠정)실적(공정공시)
|
Korean | 13.3 KB | ||
| 2025-07-30 00:00 |
Earnings Release
연결재무제표기준영업(잠정)실적(공정공시)
|
Korean | 15.2 KB | ||
| 2025-07-30 00:00 |
M&A Activity
타법인주식및출자증권취득결정
|
Korean | 18.4 KB | ||
| 2025-07-28 00:00 |
Report Publication Announcement
결산실적공시예고(안내공시)
|
Korean | 4.4 KB | ||
| 2025-07-22 00:00 |
Major Shareholding Notification
주식등의대량보유상황보고서(약식)
|
Korean | 61.3 KB | ||
| 2025-07-16 00:00 |
Major Shareholding Notification
주식등의대량보유상황보고서(약식)
|
Korean | 69.4 KB | ||
| 2025-07-14 00:00 |
Major Shareholding Notification
[기재정정]임원ㆍ주요주주특정증권등소유상황보고서
|
Korean | 27.8 KB | ||
| 2025-07-08 00:00 |
Report Publication Announcement
기업설명회(IR)개최(안내공시)
|
Korean | 6.3 KB | ||
| 2025-07-08 00:00 |
Major Shareholding Notification
주식등의대량보유상황보고서(일반)
|
Korean | 136.4 KB | ||
| 2025-07-08 00:00 |
Major Shareholding Notification
최대주주등소유주식변동신고서
|
Korean | 48.3 KB |
Automate Your Workflow. Get a real-time feed of all IL DONG PHARMACEUTICAL CO., LTD. filings delivered via API.
Market Data
Market Data Not Available
Financials & KPIs
Unlock Full Financials for IL DONG PHARMACEUTICAL CO., LTD.
This data is available as part of our premium data solutions. Contact our team for access.
Need More History? Access decades of standardized financials for IL DONG PHARMACEUTICAL CO., LTD. via our API.
Insider Transactions
| Date | Insider Name | Position | Type | Shares | Value |
|---|---|---|---|---|---|
| No insider transactions recorded for this company. | |||||
Peer Companies
